Home›Companies›Biotech & Pharma›Kayak Therapeutics

Kayak Therapeutics, Inc.

Develops targeted treatments for people with cancer.

Updated Nov 9, 2026·Latest SEC filing Aug 21, 2026·Suggest an edit

About Kayak Therapeutics

Kayak Therapeutics is a private company based in Austin, Texas, incorporated in 2025 in Delaware. It has reported $31,611,000 raised in two offerings on Form D since September 2025. Its chief executive is Josiah Hornblower.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 12, 2026May 27, 2026amended Aug 21, 2026$24,981,000of $30.0M target137$182KOptionsRule 506(b)Form D/A ↗1 earlier filing
Sep 11, 2025Sep 29, 2025$6,630,000of $10.0M target42$157KEquityRule 506(b)Form D ↗
Total, two offerings$31,611,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Kayak Therapeutics's Form D filed Aug 21, 2026.

Conor Richardson
Conor Richardson
Chief Financial Officer
Josiah Hornblower
Josiah Hornblower
President & CEO, director
Also an executive officer and director at Blue Pine Financial.
TS
Taylor Schreiber
Board Director
TB
Tyler Brous
Board Director
Also a director at ColdQuanta.

Sources

  1. SECKayak Therapeutics, Inc. Form D, filed May 27, 2026
  2. SECKayak Therapeutics, Inc. filing history
  3. CompanyTerms of Service